Vudalimab Antibody
Vudalimab is a fully human bispecific antibody that concurrently blocks PD-1 and CTLA-4 immune checkpoints, promoting tumor-specific T-cell activation. It is a research tool for investigating combination checkpoint inhibition in oncology, applicable in both in vitro T-cell functional assays and in vivo tumor model studies.
Product Specifications
Target
PD-1/PD-L1
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
5.6 mg/mL
Purity
>95% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
